Lipoprotein(a) determination in human serum using a nitrilotriacetic acid derivative immunosensing scaffold on disposable electrodes

Analytical and Bioanalytical Chemistry

Volumn 406, Issue 22, 2014, Pages 5379-5387

  Esteban Fernández De Ávila, Berta ^a   Campuzano, Susana ^a   Pedrero, María ^a   Salvador, J Pablo ^b,c   Marco, M Pilar ^b,c   Pingarrón, José M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Nanobiotechnology for Diagnostics ^*  (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Human serum; Integrated amperometric immunosensor; Lp(a); Screen printed electrode

Indexed keywords

AMINO ACIDS; ANTIBODIES; DISEASES; ELECTRODES; IMMUNOSENSORS; LIPOPROTEINS; SCAFFOLDS;

AMPEROMETRIC IMMUNOSENSORS; BIOTINYLATED ANTIBODIES; COVALENT IMMOBILIZATION; ELECTRON TRANSFER MEDIATORS; HUMAN SERUM; LP(A); SCREEN PRINTED CARBON ELECTRODE (SPCES); SCREEN PRINTED ELECTRODES;

BODY FLUIDS;

ARMORACIA RUSTICANA;

3,3',5,5'-TETRAMETHYLBENZIDINE; BENZIDINE DERIVATIVE; CARBON; HORSERADISH PEROXIDASE; LIPOPROTEIN A; NITRILOTRIACETIC ACID; STREPTAVIDIN;

BIOTINYLATION; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; ELECTROCHEMISTRY; ELECTRODE; GENETIC PROCEDURES; HUMAN; LIMIT OF DETECTION; PROCEDURES; SERUM;

BENZIDINES; BIOSENSING TECHNIQUES; BIOTINYLATION; CARBON; CARDIOVASCULAR DISEASES; ELECTROCHEMISTRY; ELECTRODES; HORSERADISH PEROXIDASE; HUMANS; LIMIT OF DETECTION; LIPOPROTEIN(A); NITRILOTRIACETIC ACID; SERUM; STREPTAVIDIN;

EID: 84907600500     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-014-7964-8     Document Type: Article

References (27)

1. Klingenberg R, Hansson GK (2009) Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J 30:2838-2844
2. Ross R (1999) Atherosclerosis is an inflammatory disease. Am Heart J 138:S419-S420
3. Malaguarnera M, Vacante M, Russo C, Malaguarnera G, Antic T, Malaguarnera L, Bella R, Pennisi G, Galvano F, Frigiola A (2013) Lipoprotein(a) in cardiovascular diseases. BioMed Res Int 2013:1-9
4. Marcovina SM, Koschinsky ML, Albers JJ, Skarlatos S (2003) Report of the national heart, lung, and blood institute workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions. Clin Chem 49:1785-1796
5. Riches K, Porter KE (2012) Lipoprotein(a): cellular effects and molecular mechanisms. Cholesterol. doi: 10.1155/2012/923289, Article ID 923289, p 10
6. Dubé JB, Boffa MB, Hegele RA, Koschinsky ML (2012) Lipoprotein(a): more interesting than ever after 50 years. Curr Opin Lipidol 23:133-140
7. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG (2009) Genetically elevated lipoprotein(a) and increased risk of myocardial Infarction. JAMA 301:2331-2339
8. Erqou S, Kaptoge S, Perry PL, Di AE, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302:412-423
9. Etingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL (1991) Lipoprotein(a) regulates plasminogen activator inhibitor-1 expression in endothelial cells: a potential mechanism in thrombogenesis. J Biol Chem 266:2459-2465
10. Tsimikas S, Hall JL (2012) Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease. J Am Coll Cardiol 60:716-721
11. Kostner KM, Oberbauer R, Hoffmann U, Stefenelli T, Maurer G, Watschinger B (1997) Urinary excretion of apo(a) in patients after kidney transplantation. Nephrol Dial Transplant 12:2673-2678
12. Suk DJ, Rifai N, Buring JE, Ridker PM (2006) Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA 296:1363-1370
13. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, Fratino P (2002) Silent coronary artery disease in type 2 diabetes mellitus: the role of lipoprotein(a), homocysteine and apo(a) polymorphism. Cardiovasc Diabetol 1:5
14. Fan J, Sun H, Unoki H, Shiomi M, Watanabe T (2001) Enhanced atherosclerosis in Lp(a) WHHL transgenic rabbits. Ann N Y Acad Sci 947:362-365
15. Imhof A, Rothenbacher D, Khuseyinova N (2003) Plasma lipoprotein Lp(a) and risk of coronary heart disease: what are the mechanisms involved? Eur J Cardiovasc Prev Rehabil 10:362-370
16. Motta M, Giugno I, Bosco S (2001) Serum lipoprotein(a) changes in acute myocardial infarction. Panminerva Med 43:77-80
17. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen M-R, Tokgözoglu L, Tybjærg-Hansen A (2010) Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2844-2853
18. Torres MB, Álvarez FH, Rodríguez Hernández A, Sorell-Gómez L, Cabalé MB (1998) Evaluación de un método rápido para la detección de niveles elevados de Lipoproteína (a): Aubiodot Lp (a). Rev Cubana Cardiol Cir Cardiovasc 24:29-35
19. Wang J, Zhang C, Gong J, Zhu Y, Fu L, Wang X, Li K (2007) Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a) by using purified human oxidized lipoprotein(a) autoantibodies as capture antibody. Clin Chim Acta 385:73-78
20. Gómez M, Valle V, Arós F, Sanz G, Sala J, Fiol M, Bruguera J, Elosua R, Molina L, Martí H, Covas MI, Rodríguez-Llorián A, Fitó M, Suárez-Pinilla MA, Amezaga R, Marrugat J (2009) Oxidized LDL, lipoprotein (a) and other emergent risk factors in acute myocardial infarction (FORTIAM study). Rev Esp Cardiol 62:373-382
21. Hayat A, Barthelmebs L, Sassolas A, Marty J-L (2011) An electrochemical immunosensor based on covalent immobilization of okadaic acid onto screen printed carbon electrode via diazotization-coupling reaction. Talanta 85:513-518
22. Huy TQ, Hanh NTH, Chung PV, Anh DD, Nga PT, Tuan MA (2011) Characterization of immobilization methods of antiviral antibodies in serum for electrochemical biosensors. Appl Surf Sci 257:7090-7095
23. Vallina-García R, García-Suárez MM, Fernández-Abedul MT, Méndez FJ, Costa-García A (2007) Oriented immobilisation of anti-pneumolysin Fab through a histidine tag for electrochemical immunosensors. Biosens Bioelectron 23:210-217
24. Valiokas R, Klenkar G, Tinazli A, Reichel A, Tampe′ R, Piehler J, Liedberg B (2008) Self-assembled monolayers containing terminal mono-, bis-, and tris-nitrilotriacetic acid groups: characterization and application. Langmuir 24:4959-4967
25. Esteban-Fernández de Ávila B, Escamilla-Gómez V, Campuzano S, Pedrero M, Pingarrón JM (2013) Disposable electrochemical magnetoimmunosensor for the determination of troponin T cardiac marker. Electroanalysis 25:51-58
26. 2+- tetradentate nitrilotriacetic acid modified disposable carbon electrodes: application to the determination of β-lactam antibiotics. Anal Chem 85:3246-3254
27. Huang Y, Bell MC, Suni II (2008) Impedance biosensor for peanut protein Ara h 1. Anal Chem 80:9157-9161